High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion Diabetes (REDIA) Study

Abstract

, et al.. High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion Diabetes (REDIA) Study.: Chronic kidney disease and metabolic syndrome. Diabetes and Metabolism, Elsevier Masson, 2007, 33 (6), pp.444-452.

Effect of metabolic syndrome and of its individual components on renal function of patients with type 2 diabetes mellitus

“…The contribution of each individual MetS component to the kidney outcome has been studied in a population-based survey in France. As observed in our experience, BP levels and triglycerides were the most important contributors (24).…”

Prevalence, treatment and control of hypertension in La Réunion: the RÉDIA population-based cohort study

“…However, the reported prevalence and incidence of cardiovascular disease or renal insufficiency appear to be very high and there is no published data due to the lack of reliable indicators and so the reasons for these high incidences are not fully understood. [5] Similar findings seem to exist concerning risk factors since diabetes is also two to three times more frequent in the French overseas territories in the Indian Ocean than in France. [6] All these characteristics, coupled with the lack of data on hypertension in the general population, make La R eunion a suitable model for study on hypertension in such settings.…”

Metabolic syndrome and its components are associated with increased chronic kidney disease risk: Evidence from a meta-analysis on 11 109 003 participants from 66 studies

“…Among the included studies, 43 were from the East Asian populations 8,9,[22][23][24][25][27][28][29]33,[35][36][37][38][39][40][41]43,44,51,52,[55][56][57][58][59]62,[65][66][67]69,[71][72][73][74][75][76][77][78][79][80]82,83 and 23 were from non-East Asian populations. 12,20,21,26,[30][31][32]34,42,…”

“…Of this, 12 studies assessed obesity based on body mass index (BMI), 9,28,36,43,45,56,65,71,72,76,79 ,83 and 35 studies used waist circumference for the assessment of obesity. 12,21,23,24,26,27,[33][34][35][38][39][40]42,44,47,48,[51][52][53][54][55][57][58][59][60][61][62][63][64]67,69,[73][74][75]82 The overall CKD risk related to higher BMI/waist circumference, as compared with lower BMI/waist circumference, was 1.22 (95% CI = 1.12-1.31), and was greater for higher values of waist circumference than BMI (Figure 3). In the stratified analysis by ethnicity, sex, and study type, the increased risk associated with higher values of BMI/waist circumference was significant in different subgroups.…”

“…The relationship between HDL-cholesterol level and CKD risk was examined in 45 studies, 9,12,21,23,24,[26][27][28][33][34][35][36][38][39][40]42,44,48,[51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][67][68][69][71][72][73][74][75][76]79,82,83 including 692 780 patients and 11 039 480 participants. In the overall analysis, the risk estimate for lower values of HDL-cholesterol, as compared with higher values, was 1.20 (95% CI = 1.11-1.30).…”